Anophthalmia and microphthalmia mean the absence of an eye and the presence of a small eye within the orbit. Anophthalmia and microphthalmia are interchangeable. Whereas, microphthalmia is a disorder in which one or both eyes are abnormally small, while anophthalmia is the absence of one or both eyes.
This report contains market size and forecasts of Anophthalmia and Microphthalmia Treatment in Global, including the following market information:
Global Anophthalmia and Microphthalmia Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Anophthalmia and Microphthalmia Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Surgery Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Anophthalmia and Microphthalmia Treatment include Pfizer, Bristol-Myers Squibb, Allergan, Aerie Pharmaceuticals, Bausch Health Companies and Regeneron Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anophthalmia and Microphthalmia Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anophthalmia and Microphthalmia Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Anophthalmia and Microphthalmia Treatment Market Segment Percentages, by Type, 2021 (%)
Surgery Therapy
Medication
Global Anophthalmia and Microphthalmia Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Anophthalmia and Microphthalmia Treatment Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Others
Global Anophthalmia and Microphthalmia Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Anophthalmia and Microphthalmia Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anophthalmia and Microphthalmia Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Anophthalmia and Microphthalmia Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Bristol-Myers Squibb
Allergan
Aerie Pharmaceuticals
Bausch Health Companies
Regeneron Pharmaceuticals